People
The people behind the science.
Leadership
Board and management.

Dr M. Ganesan
Founder & Managing Director
ganesan@kmshc.comPhD, Applied Sciences, College of Engineering, Anna University
A first-generation entrepreneur, he established his research and development centre in 2005 and has set up R&D facilities for clinical research, formulation and API development across pharma and biotech.
- R&D facility set-up
- Formulation
- API development
- Clinical research

Mr Iniyan GV-22
Executive Director
iniyan@kmshc.comMr Iniyan is Executive Director of KMS and the founder of Voxtur Clinical Research, the group company through which KMS coordinates clinical trials.
- Executive leadership
- Clinical research
- Voxtur Clinical Research

Ms G. Vasanthi
Director, Business Development
vasanthi@kmshc.comMBA
Ms Vasanthi leads business development at KMS and is the first point of contact for new partners and business enquiries. She takes each partner programme from first conversation to delivery, bringing the formulation, analytical, technology-transfer and regulatory teams onto one plan and holding it to the agreed scope, budget and timeline. Her remit covers formulation development, technology transfer and dossier development for regulatory authorities including the US FDA.
- Business development
- Partner relations
- Programme management
- Technology transfer
- Dossier development
Scientific team
Scientific leads.

L. Padmini
Manager, Quality Assurance
qa@kmshc.comM.Tech
L. Padmini manages quality assurance at KMS, which oversees development, technology transfer and validation and keeps the quality system aligned with regulators’ expectations.
- Quality assurance
- Quality management system

Pradeep M.T.P.
Clinical Investigator
principalinvestigator@microtheraps.comMBBS
Pradeep M.T.P. is the Clinical Investigator for KMS clinical programmes.
- Clinical research
- Clinical investigation

M. Malairajan
Senior Manager, Admin & Training
malaimarajan@microtheraps.comM. Malairajan is Senior Manager for administration and training at KMS.
- Administration
- Training

Dr S. John Prasanna
Head, Analytical Development / AGM
johnprasanna@kmshc.comPhD, Analytical Chemistry, JNTU Hyderabad · MSc, Applied Chemistry, Anna University · BSc, Chemistry, Madras Christian College
Dr Prasanna brings 25 years in pharmaceutical analytical development across APIs, injectables, CRO operations and regulatory compliance, with senior roles at Orchid Pharma, Syngene International, Strides Shasun Research Centre, Aurobindo Pharma Research Centre and IIT Kanpur. His work spans method development, validation and transfer, stability studies, impurity characterisation and instrument qualification on HPLC, LC-MS, GC-MS, NMR, HRMS, PXRD, DSC and FTIR, with particular depth in impurity profiling, nitrosamine risk assessment and polymorphism. He has supported DMF and ANDA submissions to ICH, US FDA and EMA requirements, has published widely and holds an Indian patent.
- Method development & validation
- Impurity profiling
- Nitrosamine & GTI risk assessment
- DMF / ANDA support
- Polymorphism & solid state
- Stability studies
- IQ/OQ/PQ
- GLP & data integrity
More than 100 scientists work across formulation, analytical development and technology transfer.V-05 Further board members and scientific profiles to be added.V-22
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · ganesan@kmshc.com · +91 97898 75194V-23
